All Community pharmacist articles – Page 9
-
NICE guidelineNICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms
-
NICE guideline
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
-
News
NICE sets out new 5-year strategy
NICE’s new strategy to 2026 sets out the institute’s ambitious vision for the future
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
NHS guideline
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
News
Shining a spotlight on emollient fire risks
Janice Perkins offers guidance on community pharmacy’s role in raising awareness of the fire risks associated with the use of emollients
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
News
New advice on AstraZeneca COVID-19 vaccine issued following rare blood clot link
New advice has been issued by the MRHA and JCVI on the link between the COVID-19 AstraZeneca vaccine and thrombosis and thrombocytopenia
-
Independent professional body guideline
AWMSG prescribing guide
Guidance on solving prescribing dilemmas, including (but not limited to) clinical responsibility, prescribing duration, and complementary therapies
-
News
NICE publishes new guideline on chronic pain
The new guidance, entitled Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain, was developed in partnership with the Royal College of Physicians.
-
News
Office for Health Promotion established to improve public health
New Office for Health Promotion will focus on prevention of poor health and improving health outcomes
-
Concise consultation card
RELIEF AND MANAGEMENT OF DRY SKIN CONDITIONS
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-35428 March 2021 -
NICE guideline
NICE CKS on infective conjunctivitis
A summary of guidance to assist community pharmacy teams with the diagnosis and management of infective conjunctivitis
-
News
NICE publishes rapid guideline on managing COVID-19
NICE has published a new rapid guideline on the management of COVID-19, including recommendations for assessment, management, therapeutics and acute complications
-
PHE/DH/DWP guideline
PHE oral health in children guidance
A summary of guidance to assist community pharmacy teams to promote the benefits of good oral health for children
-
Supplement
Supporting patients with joint pain in community pharmacy
This content is intended for UK healthcare professionals only.
PM-UK-VOLT-20-00192 Date of preparation: January 2021 -
Concise consultation card
APPROPRIATE FEVER RELIEF FOR CHILDREN
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-30635 February 2021 -
NICE guideline
NICE CKS on chickenpox
Management of chickenpox in healthy children and adults, during pregnancy and breastfeeding, and in people who are immunocompromised
